Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
larotinib (Z650)
i
Other names:
Z650
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
HEC Pharm
Drug class:
pan-HER inhibitor
Related drugs:
‹
dacomitinib (32)
FCN-411 (4)
CI-1033 (1)
AC480 (0)
JRF103 (0)
dacomitinib (32)
FCN-411 (4)
CI-1033 (1)
AC480 (0)
JRF103 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR overexpression
Esophageal Squamous Cell Carcinoma
EGFR overexpression
Esophageal Squamous Cell Carcinoma
Z650
Sensitive: C2 – Inclusion Criteria
Z650
Sensitive
:
C2
Z650
Sensitive: C2 – Inclusion Criteria
Z650
Sensitive
:
C2
EGFR amplification
Esophageal Squamous Cell Carcinoma
EGFR amplification
Esophageal Squamous Cell Carcinoma
Z650
Sensitive: C3 – Early Trials
Z650
Sensitive
:
C3
Z650
Sensitive: C3 – Early Trials
Z650
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login